(Q37961586)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Therapeutic angiogenesis for myocardial ischemia revisited: basic biological concepts and focus on latest clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

Athanasios Diamantopoulos

17 January 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

5

Nikolaos Anastasiou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Efstratios N Koletsis

3

object named as

Efstratios Koletsis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Sofoclis Mitsos

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Konstantinos Katsanos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Dimitris Karnabatidis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Dimitris Dougenis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

27 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22120824%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10456-011-9240-2

17 January 2020

exact match

0 references

cites work

Mortality by cause for eight regions of the world: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Heparin binds endothelial cell growth factor, the principal endothelial cell mitogen in bovine brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Recent insights into coronary collateral circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Molecular mechanisms of coronary collateral vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Angiogenesis and the ischaemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

De novo vasculogenesis in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

In vitro differentiation of murine embryonic stem cells. New approaches to old problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Engineering blood vessels from stem cells: recent advances and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Tumorigenesis and the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Mechanisms of angiogenesis and arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Nuclear fibroblast growth factor-2 interacts specifically with splicing factor SF3a66

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Platelet-derived endothelial cell growth factor gene therapy for limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Arteriogenesis: basic mechanisms and therapeutic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Arteriogenesis versus angiogenesis: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Arteriogenesis: mechanisms and modulation of collateral artery development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Stimulation of collateral artery growth: travelling further down the road to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Stimulation of collateral artery growth: a potential treatment for peripheral artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Signal transduction to hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Ischemia is not required for arteriogenesis in zebrafish embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Role of integrins in endothelial mechanosensing of shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

The endothelial glycocalyx mediates shear-induced changes in hydraulic conductivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

The role of the glycocalyx in reorganization of the actin cytoskeleton under fluid shear stress: a "bumper-car" model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

The endothelial glycocalyx: composition, functions, and visualization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

A critical appraisal of open- and closed-chest models of experimental myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Angiogenesis by gene therapy: a new horizon for myocardial revascularization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo. Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene ex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Targeting gene expression to the vascular wall in transgenic mice using the murine preproendothelin-1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Delivery strategies to achieve therapeutic myocardial angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Therapeutic angiogenesis for coronary artery disease: clinical trials of proteins, plasmids, adenovirus and stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Therapeutic angiogenesis for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Percutaneous gene therapy using recombinant adenoviruses encoding human herpes simplex virus thymidine kinase, human PAI-1, and human NOS3 in balloon-injured porcine coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Induction of myocardial neoangiogenesis by human growth factors. A new therapeutic approach in coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised cl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease--12-month follow-up: angiogenic gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Implantation of autologous bone marrow mononuclear cells into ischemic myocardium enhances coronary capillaries and systolic function in miniswine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Bone marrow stromal cells improve cardiac performance in healed infarcted rat hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Transcoronary transplantation of progenitor cells after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Effects of peripheral blood stem cell mobilization with granulocyte-colony stimulating factor and their transcoronary transplantation after primary stent implantation for acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Cell therapy for the treatment of coronary heart disease: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Transventricular revascularization by laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

35 years of experimental research in transmyocardial revascularization: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

The transmyocardial laser revascularization international registry report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

A UK trial-based cost--utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Diagnosis, incidence, and clinical significance of early postoperative ischemia after transmyocardial laser revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Guidelines for the clinical use of transmyocardial laser revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermitt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intramyocardial injection of DNA encoding vascular endothelial growth factor in a myocardial infarction model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

The biology of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Researchers and regulators reflect on first gene therapy death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Effects of dipyridamole on coronary collateralization and myocardial perfusion in patients with ischaemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the Endothelial Modulation in Angiogenic Therapy randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

REPAIR-AMI: stem cells for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial in

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Intrapericardial basic fibroblast growth factor induces myocardial angiogenesis in a rabbit model of chronic ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2

Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-011-9240-2